Clinical Trial Update: Telaprevir Exposure and Severe Anemia in HCV Infected Patients Treated by Tri-therapy

View source ↗

Summary

Clinical trial update notes exposure to telaprevir associated with severe anemia in hepatitis C patients treated with triple therapy; the study has been termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Telaprevir (telaprevir)

Snippet

Sponsor: University Hospital, Grenoble | Conditions: C Hepatitis, Tri Therapy | Status: TERMINATED